OpenAlex
PricingAboutJobs
Log inGet started
Work

Optimizing phase II of drug development for disease‐modifying compounds

HTML

Year: 2008
Type: article
Source: Alzheimer s & Dementia
DOI: 10.1016/j.jalz.2007.10.002
Author: Jeffrey L. Cummings
Institution: University of California, Los Angeles
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: proof-of-concept studies, dose-finding studies
SDG: Good health and well-being

Open Access status: closed

Funders: Astellas Pharma, Fondation pour la Recherche sur Alzheimer, National Institute on Aging
Award: UCLA Alzheimer's Disease Research Center
OpenAlex ID: W2166949035
FWCI: 1.024
Cites: 37
Cited by: 35
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security